医学
随机对照试验
电子健康
综合护理
不利影响
远程医疗
干预(咨询)
利克特量表
意向治疗分析
物理疗法
内科学
梅德林
初级保健
造血细胞
病人教育
急诊医学
家庭医学
临床试验
并发症
重症监护医学
实习护士
医疗保健
患者安全
临床实习
患者参与
高级实习护士
队列
护理部
研究设计
作者
Sabina De Geest,Sabine Valenta,Janette Ribaut,Kris Denhaerynck,Lynn Leppla,Alexandra Teynor,Sabine Gerull,Jörg P. Halter,Jakob Robert Passweg,Jens Eckstein,Michael Simon
出处
期刊:Research Square
日期:2025-10-30
标识
DOI:10.21203/rs.3.rs-7837069/v1
摘要
Abstract eHealth-supported integrated care models (eICMs) enable early complication management and foster self-management. The SMILe-ICM, an Advanced Practice Nurse (APN)-led eICM for patients after hematopoietic cell transplantation, was previously tested in Germany and adapted for Switzerland.This study evaluated the Swiss SMILe-ICM in a hybrid effectiveness–implementation randomized controlled trial. Implementation outcomes (acceptability, feasibility, appropriateness) were assessed via 5-point Likert scales (higher = better). The primary effectiveness outcome was time to first rehospitalization; secondary outcomes included rehospitalization rates, durations, and causes, as well as survival, dropout, recruitment time, and adverse events.From April 2021 to July 2022, 80 patients were randomized (1:1) to intervention (IG) or usual care (UCG). Dropout was 35%; recruitment ended nine months early. APNs and patients rated implementation outcomes very high (mean = 4.9, SD = 0.3). Median time to first unplanned rehospitalization was longer in IG (86.5 vs. 56.0 days). Group differences were non-significant (HR = 0.84; p = 0.57) but causes differed (relapse (IG) vs. infection (UCG)). One-year survival was comparable (81% vs. 83%, HR = 1.17; p = 0.74). No adverse events occurred.Despite being underpowered, findings confirm high implementation success and suggest effectiveness going in hypothesized trends. Larger multicenter cluster-RCTs are warranted.
科研通智能强力驱动
Strongly Powered by AbleSci AI